Life Sciences & Health Care
Formerly know as "Health Sciences"
As life sciences and health care organizations face increasing pressures, many are looking at M&A to leverage economies of scale and drive the pace of innovation. What does the landscape look like so far this year, and what’s coming next? Understand what M&A in health care looks like today and where it may be headed tomorrow.
With health care organizations now well along their journey to value-based care, new regulations like MACRA are bringing that goal into the forefront faster. How are alternative payment models faring in terms of delivering quality care and reducing costs, and how does this shift play into new ways of thinking about care models? Learn results from Deloitte Center for Health Solutions’ research on strategies for bundled payments and post-acute care.
Facing continued rising costs and inconsistent outcomes, the health care industry is ripe for innovation. What emerging technologies could help stakeholders make exponential leaps toward improved care and health outcomes while reducing costs? Learn how exponential technologies could finally break the constraints of fee-for-service-based health care and help deliver care in ways previously not thought possible.
New innovations could dramatically change health care, especially relating to chronic and life-threatening conditions. How can biopharma and medtech companies leverage such innovations to advance breakthrough therapies and provide better patient-centered care? Learn about Deloitte’s RWE Benchmark Survey and how organizations can effectively move toward patient-centered care.
At the heart of health care: When patients become engaged power players
February 15, 2017
Breaking the mold: Reinvigorating biopharmaceutical innovation
January 24, 2017